{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:05:06Z","timestamp":1770818706435,"version":"3.50.1"},"reference-count":117,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HIV Ther."],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.2217\/hiv.09.8","type":"journal-article","created":{"date-parts":[[2009,4,30]],"date-time":"2009-04-30T13:41:49Z","timestamp":1241098909000},"page":"269-282","source":"Crossref","is-referenced-by-count":6,"title":["Type I Interferon in HIV Treatment: From Antiviral Drug to Therapeutic Target"],"prefix":"10.2217","volume":"3","author":[{"given":"Adriano","family":"Boasso","sequence":"first","affiliation":[{"name":"Department of Immunology, Division of Investigative Science, Faculty of Medicine, Imperial College, Chelsea & Westminster Hospital, 369 Fulham Road, LondonSW10 9NH, UK."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,4,30]]},"reference":[{"key":"e_1_3_2_3_1_1","doi-asserted-by":"publisher","DOI":"10.1098\/rspb.1957.0048"},{"key":"e_1_3_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R700004200"},{"key":"e_1_3_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.69.6.912"},{"key":"e_1_3_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.14.4.778-809.2001"},{"key":"e_1_3_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2007.06.012"},{"key":"e_1_3_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.19.3.2098"},{"key":"e_1_3_2_3_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001432-200206000-00008"},{"key":"e_1_3_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.9.6421"},{"key":"e_1_3_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.6.3164"},{"key":"e_1_3_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C100501200"},{"key":"e_1_3_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.1006\/smim.1998.0136"},{"key":"e_1_3_2_3_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/3-540-32636-7_2"},{"key":"e_1_3_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2007.10.007"},{"key":"e_1_3_2_3_14_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.18.1.451"},{"key":"e_1_3_2_3_15_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.162.7.3926"},{"key":"e_1_3_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2006.06.003"},{"key":"e_1_3_2_3_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2007.00562.x"},{"key":"e_1_3_2_3_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2358"},{"key":"e_1_3_2_3_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni1141"},{"key":"e_1_3_2_3_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1590"},{"key":"e_1_3_2_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2009.01.004"},{"key":"e_1_3_2_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2007.08.015"},{"key":"e_1_3_2_3_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)92144-0"},{"key":"e_1_3_2_3_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0166-3542(94)90068-X"},{"key":"e_1_3_2_3_25_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20051512"},{"key":"e_1_3_2_3_26_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.26.021607.090350"},{"key":"e_1_3_2_3_27_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M406760200"},{"key":"e_1_3_2_3_28_1","doi-asserted-by":"publisher","DOI":"10.1089\/jir.1986.6.543"},{"key":"e_1_3_2_3_29_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.173.1.277"},{"key":"e_1_3_2_3_30_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.169.3.1137"},{"key":"e_1_3_2_3_31_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02211-08"},{"key":"e_1_3_2_3_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature06553"},{"key":"e_1_3_2_3_33_1","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1999.9869"},{"key":"e_1_3_2_3_34_1","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0306154"},{"key":"e_1_3_2_3_35_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI26032"},{"key":"e_1_3_2_3_36_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0707244104"},{"key":"e_1_3_2_3_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000232231.34253.bd"},{"key":"e_1_3_2_3_38_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.4.2887"},{"key":"e_1_3_2_3_39_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.16.8433-8445.2002"},{"key":"e_1_3_2_3_40_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.4.1648-1657.2000"},{"key":"e_1_3_2_3_41_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01545-07"},{"key":"e_1_3_2_3_42_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-06-162651"},{"key":"e_1_3_2_3_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-08-3058"},{"key":"e_1_3_2_3_44_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-03-1243"},{"key":"e_1_3_2_3_45_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0600363103"},{"key":"e_1_3_2_3_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm987"},{"key":"e_1_3_2_3_47_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-04-151712"},{"key":"e_1_3_2_3_48_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002961"},{"key":"e_1_3_2_3_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2008.05.009"},{"key":"e_1_3_2_3_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.1871"},{"key":"e_1_3_2_3_51_1","article-title":"Glycerol monolaurate prevents mucosal SIV transmission.","author":"Li Q","year":"2009","unstructured":"Li Q , EstesJD, SchlievertPMet al.: Glycerol monolaurate prevents mucosal SIV transmission.Nature (2009) (Epub ahead of print).","journal-title":"Nature"},{"key":"e_1_3_2_3_52_1","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1994.1617"},{"key":"e_1_3_2_3_53_1","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1993.9.957"},{"key":"e_1_3_2_3_54_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.68.3.1983-1986.1994"},{"key":"e_1_3_2_3_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1511"},{"key":"e_1_3_2_3_56_1","doi-asserted-by":"publisher","DOI":"10.2174\/1381612023393242"},{"key":"e_1_3_2_3_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/0166-3542(82)90030-4"},{"key":"e_1_3_2_3_58_1","doi-asserted-by":"publisher","DOI":"10.1586\/14737175.7.3.227"},{"key":"e_1_3_2_3_59_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-103-5-750"},{"key":"e_1_3_2_3_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)90811-2"},{"key":"e_1_3_2_3_61_1","first-page":"46","article-title":"The role of \u03b1-interferon in patients with human immunodeficiency virus infection.","volume":"18","author":"Lane HC","year":"1991","unstructured":"Lane HC : The role of \u03b1-interferon in patients with human immunodeficiency virus infection.Semin. Oncol.18, 46\u201352(1991).","journal-title":"Semin. Oncol."},{"key":"e_1_3_2_3_62_1","doi-asserted-by":"publisher","DOI":"10.1177\/135965350801301S04"},{"key":"e_1_3_2_3_63_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03695.x"},{"key":"e_1_3_2_3_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0684.2007.00221.x"},{"key":"e_1_3_2_3_65_1","first-page":"3","article-title":"Influence of GBV-C infection on the endogenous activation of the IFN system in HIV-1 co-infected patients.","volume":"52","author":"Capobianchi MR","year":"2006","unstructured":"Capobianchi MR , LalleE, MartiniFet al.: Influence of GBV-C infection on the endogenous activation of the IFN system in HIV-1 co-infected patients.Cell Mol. Biol.52, 3\u20138(2006).","journal-title":"Cell Mol. Biol."},{"key":"e_1_3_2_3_66_1","doi-asserted-by":"publisher","DOI":"10.1177\/039463200802100118"},{"key":"e_1_3_2_3_67_1","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2007.0076"},{"key":"e_1_3_2_3_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2008.02050.x"},{"key":"e_1_3_2_3_69_1","doi-asserted-by":"publisher","DOI":"10.2165\/00063030-200721060-00006"},{"key":"e_1_3_2_3_70_1","first-page":"1101","article-title":"Topical immunomodulation in dermatology: potential of Toll-like receptor agonists.","volume":"30","author":"Hengge UR","year":"2004","unstructured":"Hengge UR , RuzickaT: Topical immunomodulation in dermatology: potential of Toll-like receptor agonists.Dermatol. Surg.30, 1101\u20131112(2004).","journal-title":"Dermatol. Surg."},{"key":"e_1_3_2_3_71_1","doi-asserted-by":"publisher","DOI":"10.5070\/D34VW339W4"},{"key":"e_1_3_2_3_72_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/48.6.751"},{"key":"e_1_3_2_3_73_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20052433"},{"key":"e_1_3_2_3_74_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.12.7269"},{"key":"e_1_3_2_3_75_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.4.2097"},{"key":"e_1_3_2_3_76_1","doi-asserted-by":"publisher","DOI":"10.1086\/515343"},{"key":"e_1_3_2_3_77_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.moh.0000166496.18773.e3"},{"key":"e_1_3_2_3_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2008.05.033"},{"key":"e_1_3_2_3_79_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0611353104"},{"key":"e_1_3_2_3_80_1","first-page":"114","article-title":"HIV disease progression: immune activation, microbes, and a leaky gut.","volume":"15","author":"Douek D","year":"2007","unstructured":"Douek D : HIV disease progression: immune activation, microbes, and a leaky gut.Top. HIV Med.15, 114\u2013117(2007).","journal-title":"Top. HIV Med."},{"key":"e_1_3_2_3_81_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI33034"},{"key":"e_1_3_2_3_82_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2008.02043.x"},{"key":"e_1_3_2_3_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2006.09.016"},{"key":"e_1_3_2_3_84_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.6.3315"},{"key":"e_1_3_2_3_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(03)00208-5"},{"key":"e_1_3_2_3_86_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050821"},{"key":"e_1_3_2_3_87_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.3.1746"},{"key":"e_1_3_2_3_88_1","doi-asserted-by":"publisher","DOI":"10.1086\/314660"},{"key":"e_1_3_2_3_89_1","first-page":"904","article-title":"Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T-cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study.","volume":"6","author":"Giorgi JV","year":"1993","unstructured":"Giorgi JV , LiuZ, HultinLE, CumberlandWG, HennesseyK, DetelsR: Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T-cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study.J. Acquir. Immune Defic. Syndr.6, 904\u2013912(1993).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"e_1_3_2_3_90_1","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199710010-00003"},{"key":"e_1_3_2_3_91_1","doi-asserted-by":"publisher","DOI":"10.1177\/0961203308090020"},{"key":"e_1_3_2_3_92_1","doi-asserted-by":"publisher","DOI":"10.1053\/jinf.2001.0959"},{"key":"e_1_3_2_3_93_1","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199609000-00009"},{"key":"e_1_3_2_3_94_1","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199904010-00006"},{"key":"e_1_3_2_3_95_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050914"},{"key":"e_1_3_2_3_96_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.10.5590"},{"key":"e_1_3_2_3_97_1","doi-asserted-by":"publisher","DOI":"10.1177\/0961203393002001031"},{"key":"e_1_3_2_3_98_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1988.tb00777.x"},{"key":"e_1_3_2_3_99_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0400937101"},{"key":"e_1_3_2_3_100_1","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1990.6.481"},{"key":"e_1_3_2_3_101_1","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200506010-00001"},{"key":"e_1_3_2_3_102_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-004-0180-4"},{"key":"e_1_3_2_3_103_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-034785"},{"key":"e_1_3_2_3_104_1","first-page":"3","article-title":"Are blockers of gp120\/CD4 interaction effective inhibitors of HIV-1 immunopathogenesis?","volume":"8","author":"Herbeuval JP","year":"2006","unstructured":"Herbeuval JP , ShearerGM: Are blockers of gp120\/CD4 interaction effective inhibitors of HIV-1 immunopathogenesis?AIDS Rev.8, 3\u20138(2006).","journal-title":"AIDS Rev."},{"key":"e_1_3_2_3_105_1","first-page":"145","article-title":"Phase I study of high-dose, intravenous rsCD4 in subjects with advanced HIV-1 infection.","volume":"9","author":"Schacker T","year":"1995","unstructured":"Schacker T , CollierAC, CoombsRet al.: Phase I study of high-dose, intravenous rsCD4 in subjects with advanced HIV-1 infection.J. Acquir. Immune Defic. Syndr. Hum. Retrovirol.9, 145\u2013152(1995).","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retrovirol."},{"key":"e_1_3_2_3_106_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI34823"},{"key":"e_1_3_2_3_107_1","doi-asserted-by":"publisher","DOI":"10.2174\/138920007780362527"},{"key":"e_1_3_2_3_108_1","first-page":"141","article-title":"Do regulatory T-cells play a role in AIDS pathogenesis?","volume":"8","author":"Boasso A","year":"2006","unstructured":"Boasso A , VaccariM, NilssonJet al.: Do regulatory T-cells play a role in AIDS pathogenesis?AIDS Rev.8, 141\u2013147(2006).","journal-title":"AIDS Rev."},{"key":"e_1_3_2_4_2_1","unstructured":"Phase III Randomized Double-Blind Placebo Controlled Study To Evaluate the Safety and Efficacy of Betaseron in AIDS and Advanced ARC Patients Receiving a Reduced-Dose AZT Regimen (NCT00002238). http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00002238?term=NCT00002238&rank=1"},{"key":"e_1_3_2_4_3_1","unstructured":"A Randomized Dose-Ranging Study of Alferon LDO in Asymptomatic HIV+ Subjects (NCT00215852). http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00215852?term=NCT00215852&rank=1"},{"key":"e_1_3_2_4_4_1","unstructured":"Antiviral Activity of Peg-IFN-\u03b1-2A in Chronic HIV-1 Infection (NCT00594880). http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00594880?term=NCT00594880&rank=1"},{"key":"e_1_3_2_4_5_1","unstructured":"Safety and Tolerability of MEDI-545 in Patients Who Have Systemic Lupus Erythematosus (SLE) (NCT00299819). http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00299819?term=NCT00299819&rank=1"},{"key":"e_1_3_2_4_6_1","unstructured":"A Multicenter Study to Evaluate the Safety and Tolerability of Single-Dose for MEDI-545 (CP145) (NCT00472758). http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00472758?term=NCT00472758&rank=1"},{"key":"e_1_3_2_4_7_1","unstructured":"A Study to Evaluate the Safety and Tolerability of Multiple Intravenous Doses of MEDI 545 in Patients With Systemic Lupus Erythematosus (NCT00482989). http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00482989?term=NCT00482989&rank=1"},{"key":"e_1_3_2_4_8_1","unstructured":"A Study to Evaluate Safety of Multi-Dose MEDI-545 in Adult Patients With Dermatomyositis or Polymyositis (NCT00533091). http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00533091?term=NCT00533091&rank=1"},{"key":"e_1_3_2_4_9_1","unstructured":"A Study to Evaluate Safety and Tolerability of Subcutaneous Doses of MEDI-545 in Subjects With Lupus (NCT00657189). http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00657189?term=NCT00657189&rank=1"},{"key":"e_1_3_2_4_10_1","unstructured":"Investigating the Anti-Human Immunodeficiency Virus (HIV) & Anti-Inflammatory Effect of Chloroquine (NCT00308620). http:\/\/clinicaltrials.gov\/ct2\/results?term=NCT00308620"}],"container-title":["HIV Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/hiv.09.8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T17:35:02Z","timestamp":1715967302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/hiv.09.8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,30]]},"references-count":117,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["10.2217\/hiv.09.8"],"URL":"https:\/\/doi.org\/10.2217\/hiv.09.8","relation":{},"ISSN":["1758-4310"],"issn-type":[{"value":"1758-4310","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4,30]]}}}